Mr. Clement Ngai is a Partner of the Intellectual Property Group in the Shanghai office. He advises extensively on IP issues relating to technology research development in China; particularly for clients in the life science industries such as pharmaceutical, biotech, medical devices and other regulated sectors. He regularly assists clients in market access, IP licensing, clinical trials, product registration and recalls, and technology transfers in China. Clement is also a seasoned litigator who has handled many high profile IP litigations involving complicated technology. Having worked many years as an in-house legal counsel in US technology companies, Clement understands the internal needs of clients and gives practical advices.